Focus on lipoprotein(a): The time is now

Focus on lipoprotein(a): The time is now

Saved in:

Bibliographic Details
Main Authors:	Ya‐hui Lin, Qiong Yang, Zhou Zhou
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Series:	iLabmed
Subjects:	lipoprotein (a) cardiovascular diseases Chinese population laboratory tests
Online Access:	https://doi.org/10.1002/ila2.19
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Temporal trends in lipoprotein(a) testing among United States veterans from 2014 to 2023
by: Sofia E. Gomez, et al.
Published: (2024-12-01)

The role of lipoprotein a in cardiac risk stratification and evaluation of hypolipemizing treatment
by: Maria Maciąg, et al.
Published: (2024-11-01)

Statins—Their Effect on Lipoprotein(a) Levels
by: Marcin Mateusz Granat
Published: (2025-01-01)

Lipoprotein(a) and panvascular disease
by: Ruiyan Xu, et al.
Published: (2025-05-01)

Lipoprotein(a) as a risk factor for cardiovascular diseases - focus on ischemic stroke (a position paper)
by: Ia. B. Skiba, et al.
Published: (2024-06-01)

Lipoprotein (a) Screening, and What's Next?
by: Pasławska Anna, et al.
Published: (2024-12-01)

Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action?
by: Isabella Fichtner, et al.
Published: (2024-12-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

Lipoprotein(a) and Cardiovascular Disease in People Living With HIV: The Next Horizon
by: David B. Hanna, et al.
Published: (2024-12-01)

Lipoprotein(a) as underestimated cardiovascular risk factor in Russia. Time to introduce into clinical practice
by: O. I. Afanasyeva, et al.
Published: (2024-10-01)

Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice
by: A. I. Sapina, et al.
Published: (2025-01-01)

Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01)

Lipoprotein(a) and cardiovascular disease: Evidence, recommendations and emerging therapies
by: Wong Nathan D.
Published: (2025-01-01)

Results of a national survey ‘It’s time for Lp(a)’ regarding the awareness, attitudes and practices of bulgarian cardiologists for testing lipoprotein(a)
by: A. Borizanova, et al.
Published: (2025-05-01)

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore
by: Wann Jia Loh, et al.
Published: (2025-02-01)

Lipoprotein(a) throughout life in women
by: Pablo Corral, et al.
Published: (2024-12-01)

The Relationship between Lipoprotein A and the Prevalence of Multivessel Coronary Artery Disease in Young Patients with Acute Myocardial Infarction: An Observational Study
by: Ionut Cezar Buciu, et al.
Published: (2024-09-01)

Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City
by: Maisha Maliha, et al.
Published: (2025-01-01)

Predictors of lipoprotein(a) variability in clinical practice and their impact on cardiovascular risk
by: Hyung Joon Joo, et al.
Published: (2025-07-01)

Utilizing the Electronic Health Record to Evaluate Lipoprotein(a) Testing Within a Large Regional Health System
by: Kamil F. Faridi, MD, MSc, et al.
Published: (2025-01-01)

Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now
by: S. A. Shalnova, et al.
Published: (2024-12-01)

Editorial: Cardiovascular risk and lipoprotein(a): beyond LDL cholesterol
by: Giuseppe Mandraffino, et al.
Published: (2025-05-01)

Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
by: Hesham Sheashaa, et al.
Published: (2025-01-01)

Lipoprotein(a): Assessing the Current Knowledge and Gaps in Screening and Treatment—A Narrative Review
by: Octavian Amaritei, et al.
Published: (2025-04-01)

Exploring the Relationship Between Lipoprotein (a) Level and Myocardial Infarction Risk: An Observational Study
by: Ionut Cezar Buciu, et al.
Published: (2024-11-01)

Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort
by: Tessa M. Zeis, MD, et al.
Published: (2025-03-01)

Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian Individuals
by: Darshan Patel, et al.
Published: (2025-07-01)

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Lipoprotein(a) in the diagnosis of cardiovascular risk. The values of lipoprotein (a) and apolipoprotein B in the adult population of Krasnoyarsk
by: V. S. Emelyanchik, et al.
Published: (2023-08-01)

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality among hypertension patients
by: Xiaozhou Su, et al.
Published: (2025-02-01)

Lipoprotein(a) as an early marker of cardiovascular events in high-risk subjects: insights from the Moli-sani cohort study
by: Francesco Gianfagna, et al.
Published: (2025-07-01)

Oxidative impact on lipoprotein structure: Insights from dynamic light scattering
by: Nickolette Kong, et al.
Published: (2025-03-01)

2024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings.
by: Bożena Sosnowska, et al.
Published: (2025-02-01)

The Impact of Diet on Lipoprotein(a) Levels
by: Michał Stojko, et al.
Published: (2024-10-01)

Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01)

Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease
by: Robert S. Rosenson, et al.
Published: (2025-06-01)

Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders
by: S. A. Shalnova, et al.
Published: (2022-09-01)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

Association of the remnant cholesterol to high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients
by: Zebin Wang, et al.
Published: (2025-03-01)